The demand for prescription drugs as a function of cost-sharing

Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data

“…Our lack of evidence of moral hazard in Finland is in line with Leibowitz, Manning and Newhouse (1985), Hellerstein (1998), and Mott and Cline (2002) who all find no evidence of moral hazard in the US, but is in contrast with Lundin (2000) and Granlund (2013) who both find evidence of moral hazard in Sweden.…”

“…Our results add further support to the studies to date which have found no evidence on moral hazard in drug prescriptions markets (Leibowitz, Manning and Newhouse, 1985;Hellerstein, 1998;Mott and Cline, 2002).…”

Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data

“…Our lack of evidence of moral hazard in Finland is in line with Leibowitz, Manning and Newhouse (1985), Hellerstein (1998), and Mott and Cline (2002) who all find no evidence of moral hazard in the US, but is in contrast with Lundin (2000) and Granlund (2013) who both find evidence of moral hazard in Sweden.…”

“…Our results add further support to the studies to date which have found no evidence on moral hazard in drug prescriptions markets (Leibowitz, Manning and Newhouse, 1985;Hellerstein, 1998;Mott and Cline, 2002).…”

The effect of pharmaceutical co-payment increase on the use of social assistance—A natural experiment study

“…Evidence fairly consistently shows that increases and introductions of cost sharing for medicines reduces their utilization, with effects extending to necessary medications, and particularly affecting vulnerable groups. The findings are in line with the observed behavioral effects of cost sharing in health care in more general terms [29], including evidence from a randomized controlled trial (RCT): the Rand Health Insurance Experiment conducted in the US in the 1970's, found higher cost sharing to be associated with decreased use of all types of health care services, including medicines [30,31].…”

The Impact of Cost Sharing on Antidepressant Use Among Older Adults in British Columbia

“…Doubling copayments has reduced antidepressant use by 25% (40). The RAND health insurance experiment found that medication use was reduced by 33% in plans with 95% cost sharing (roughly equivalent to the uncovered period before patients reach their deductible in our study) (37,38). Introduction of a 25% coinsurance and income-based deductible policy among seniors in Ontario was associated with a 9% reduction in use of essential medications (22).…”

Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data

“…Our lack of evidence of moral hazard in Finland is in line with Leibowitz, Manning and Newhouse (1985), Hellerstein (1998), and Mott and Cline (2002) who all find no evidence of moral hazard in the US, but is in contrast with Lundin (2000) and Granlund (2013) who both find evidence of moral hazard in Sweden.…”

“…Our results add further support to the studies to date which have found no evidence on moral hazard in drug prescriptions markets (Leibowitz, Manning and Newhouse, 1985;Hellerstein, 1998;Mott and Cline, 2002).…”

The effect of pharmaceutical co-payment increase on the use of social assistance—A natural experiment study

“…Evidence fairly consistently shows that increases and introductions of cost sharing for medicines reduces their utilization, with effects extending to necessary medications, and particularly affecting vulnerable groups. The findings are in line with the observed behavioral effects of cost sharing in health care in more general terms [29], including evidence from a randomized controlled trial (RCT): the Rand Health Insurance Experiment conducted in the US in the 1970's, found higher cost sharing to be associated with decreased use of all types of health care services, including medicines [30,31].…”

The Impact of Cost Sharing on Antidepressant Use Among Older Adults in British Columbia

“…Doubling copayments has reduced antidepressant use by 25% (40). The RAND health insurance experiment found that medication use was reduced by 33% in plans with 95% cost sharing (roughly equivalent to the uncovered period before patients reach their deductible in our study) (37,38). Introduction of a 25% coinsurance and income-based deductible policy among seniors in Ontario was associated with a 9% reduction in use of essential medications (22).…”

Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data

“…Our lack of evidence of moral hazard in Finland is in line with Leibowitz, Manning and Newhouse (1985), Hellerstein (1998), and Mott and Cline (2002) who all find no evidence of moral hazard in the US, but is in contrast with Lundin (2000) and Granlund (2013) who both find evidence of moral hazard in Sweden.…”

“…Our results add further support to the studies to date which have found no evidence on moral hazard in drug prescriptions markets (Leibowitz, Manning and Newhouse, 1985;Hellerstein, 1998;Mott and Cline, 2002).…”

The effect of pharmaceutical co-payment increase on the use of social assistance—A natural experiment study

“…Evidence fairly consistently shows that increases and introductions of cost sharing for medicines reduces their utilization, with effects extending to necessary medications, and particularly affecting vulnerable groups. The findings are in line with the observed behavioral effects of cost sharing in health care in more general terms [29], including evidence from a randomized controlled trial (RCT): the Rand Health Insurance Experiment conducted in the US in the 1970's, found higher cost sharing to be associated with decreased use of all types of health care services, including medicines [30,31].…”

The Impact of Cost Sharing on Antidepressant Use Among Older Adults in British Columbia

“…Doubling copayments has reduced antidepressant use by 25% (40). The RAND health insurance experiment found that medication use was reduced by 33% in plans with 95% cost sharing (roughly equivalent to the uncovered period before patients reach their deductible in our study) (37,38). Introduction of a 25% coinsurance and income-based deductible policy among seniors in Ontario was associated with a 9% reduction in use of essential medications (22).…”